DAISUKE NAKADA to Mutation
This is a "connection" page, showing publications DAISUKE NAKADA has written about Mutation.
Connection Strength
0.387
-
CHEK2 loss endows chemotherapy resistance to hematopoietic stem cells. Leukemia. 2026 Mar; 40(3):511-521.
Score: 0.090
-
Distinct landscape and clinical implications of therapy-related clonal hematopoiesis. J Clin Invest. 2024 Oct 01; 134(19).
Score: 0.082
-
Environmental influences on clonal hematopoiesis. Exp Hematol. 2020 03; 83:66-73.
Score: 0.059
-
Clonal expansion and myeloid leukemia progression modeled by multiplex gene editing of murine hematopoietic progenitor cells. Exp Hematol. 2018 08; 64:33-44.e5.
Score: 0.053
-
Role of the C terminus of Mec1 checkpoint kinase in its localization to sites of DNA damage. Mol Biol Cell. 2005 Nov; 16(11):5227-35.
Score: 0.022
-
Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation. Nat Genet. 2025 Jul; 57(7):1695-1707.
Score: 0.022
-
Requirement of the Mre11 complex and exonuclease 1 for activation of the Mec1 signaling pathway. Mol Cell Biol. 2004 Nov; 24(22):10016-25.
Score: 0.021
-
The ATM-related Tel1 protein of Saccharomyces cerevisiae controls a checkpoint response following phleomycin treatment. Nucleic Acids Res. 2003 Mar 15; 31(6):1715-24.
Score: 0.018
-
Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nat Commun. 2020 10 21; 11(1):5327.
Score: 0.016
-
Association of Rad9 with double-strand breaks through a Mec1-dependent mechanism. Mol Cell Biol. 2004 Apr; 24(8):3277-85.
Score: 0.005